Nelfinavir increased the intracellular level of doxorubicin in doxorubicin-resistant breast cancer cells via inhibiting the function and membrane localization P-gp, which was associated with downregulation of the PI3K–Akt pathway and activation of ER stress [60]. Here, AKT1 is linked to breast carcinoma.